Association of response to programmed death receptor 1 (PD-1) blockade with pembrolizumab (MK-3475) with an interferon-inflammatory immune gene signature

Antoni Ribas, Caroline Robert, F. Stephen Hodi, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Hassane M. Zarour, Richard Kefford, Andrey Loboda, Andrew Albright, Soonmo Peter Kang, Scot Ebbinghaus, Jennifer Yearley, Erin Murphy, Michael Nebozhyn, Jared K. Lunceford, Terri McClanahan, Mark Ayers, Adil Daud

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)3001
    Number of pages1
    JournalJournal of Clinical Oncology
    Volume33
    Issue number15 supplement
    DOIs
    Publication statusPublished - 20 May 2015
    EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
    Duration: 31 May 20134 Jun 2013

    Cite this